InnoCare Releases 2021 Half Year Results and Business Highlights
- Sunday, August 29, 2021, 7:11
- PR Newswire
- Add a comment
BEIJING, Aug. 29, 2021 /PRNewswire/ — InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced 2021 half year results which ended on June 30, 2021. Dr. Jasmine Cui, Co-founder, Chairwoman and CEO of InnoCare, said, “On…
About the Author
admin has written 20652 stories on this site.